Related Experiment Video
Updated: Jul 13, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Optimal revascularization strategy for diabetic patients with multivessel coronary artery disease: the duel between
Insights
Coronary artery bypass surgery was preferred for diabetic patients with multivessel coronary artery disease. New trials will determine the best revascularization strategy with drug-eluting stents.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Diabetic Complications
Background:
- Historical preference for coronary artery bypass surgery (CABG) over percutaneous coronary intervention (PCI) in diabetic patients with multivessel coronary artery disease (CAD) was based on trials predating drug-eluting stents.
- Previous ACC/AHA guidelines recommended CABG for acute coronary syndromes in this population, assuming graft availability.
Discussion:
- The advent of drug-eluting stents (DES) may alter the risk-benefit profile of PCI versus CABG in diabetic patients with multivessel CAD.
- The limitations of older trials (BARI, ARTS I) and meta-analyses necessitate re-evaluation in light of modern interventional techniques.
Key Insights:
- Current evidence suggests CABG may be superior for diabetic patients with multivessel CAD when internal mammary artery grafts are feasible.
- Recommendations from 2002 may not reflect current optimal treatment due to technological advancements in PCI.
Outlook:
- Ongoing trials such as FREEDOM, CARDia, and SYNTAX are crucial for establishing the optimal revascularization strategy.
- Future research will clarify whether PCI with DES can match or surpass CABG outcomes in this high-risk diabetic population.
Abstract:
Given the results of the BARI and ARTS I trials and a meta-analysis, coronary artery bypass surgery has been preferred to percutaneous coronary intervention in diabetics with multivessel coronary artery disease requiring hypoglycemic treatment and in whom internal mammary artery grafts can be used. This approach was strongly recommended in a 2002 ACC/AHA Task Force on the management of patients with acute coronary syndrome. But, these recommendations were made before the availability of drug-eluting stents. We strongly believe that the ongoing, multi-centre FREEDOM, CARDia and SYNTAX trials will elucidate the optimal revascularization strategy for diabetic patients with multivessel disease in the near future.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Diabetic Retinopathy